Shionogi Aktie

12,80EUR 0,40EUR 3,23%
Shionogi für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN: 855648 / ISIN: JP3347200002
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 78,39
Sumitomo Life Insurance Co. 6,27
Nomura Asset Management Co., Ltd. 6,21
Shionogi & Co., Ltd. 3,39
Sumitomo Mitsui Banking Pension Fund 3,20
Sumitomo Mitsui Trust Asset Management Co., Ltd. 3,05
Nikko Asset Management Co., Ltd. 3,01
Nomura Asset NEXT FUNDS NIKKEI 225 ETF (1321) 3,01
BlackRock Fund Advisors 3,01
Nippon Life Insurance Co. 2,84
Nomura Asset NEXT FUNDS TOPIX ETF (1306) 2,19
Ping An Insurance (Group) Co. of China Ltd. 2,14
BlackRock Japan Co. Ltd. 2,08
Mitsubishi UFJ Asset Management Co., Ltd. 1,53
Nikko Exchange Traded Index Fund 225 1,45

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 5 222 5 485 5 693 5 680 4 959
Umsatz pro Mitarbeiter in Mio. EUR 63,84 54,18 58,87 75,12 87,74

Bilanz (in Mio. JPY) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 516 026 556 238 659 205 784 192 784 205
Summe Anlagevermögen 355 500 442 754 491 396 527 608 632 713
Summe Aktiva 871 526 998 992 1 150 601 1 311 800 1 416 918

Bilanz (in Mio. JPY) - Passiva

2020 2021 2022 2023 2024
Gesamtverschuldung/ -verbindlichkeiten 8 152 7 987 6 674 9 411 11 620
Summe Fremdkapital 106 913 134 438 157 314 189 919 164 354
Summe Eigenkapital 764 611 864 550 993 285 1 121 878 1 252 562
Summe Passiva 871 524 998 988 1 150 599 1 311 797 1 416 916

Adresse

3-1-8 Dosho-machi, 541-0045 Osaka
Telefon +81 (6) 6202-2161
Fax +81 (6) 6229-9596
Internet http://www.shionogi.co.jp

Management

Akira Okamoto
Auditor
Fumi Takatsuki
Independent Outside Director
Hiroshi Ozaki
Independent Outside Director
Isao Teshirogi
Chairman, President & Chief Executive Officer
John Keller
Senior Executive Officer, Head-R&D
Kazuhiro Hatanaka
Manager-Business Strategy
Keiichi Ando
Independent Outside Director
Kohji Hanasaki
Senior Executive Officer & Head-Supply Chain
Masako Kudo
Manager-Finance & Accounting
Noriyuki Kishida
Auditor
Takaoki Fujiwara
Independent Outside Director
Takeshi Shiota
Executive Officer & GM-Quality Assurance
Takuko Sawada
Vice Chairman
Yasuetsu Imune
General Manager-Drug Discovery Research